← Azimuth Daily
Capturing data…
Capturing data…
STAT News · Science & Medicine
View sourceMedicare is ending certain payment mechanisms that previously allowed medical devices designated as 'breakthrough' by the FDA to receive extra reimbursement. This change likely affects programs like the New Technology Add-on Payment (NTAP) or Transitional Pass-Through Payment (TPTP), which were designed to incentivize innovation by providing temporary additional payments for novel devices. The elimination of these pathways could reduce financial incentives for developing and adopting breakthrough medical technologies.
The claim is based on a report from STAT News, which is a reputable health news outlet. The provenance tier indicates a primary source, meaning the article likely cites an official Medicare rule or announcement. Without reading the full article, the exact details of which pathways are eliminated and the effective date cannot be verified, but the core claim is consistent with known Medicare policy processes.
This item is treated as current news, with no indication of being a resurfaced older story; it likely reflects a recent Medicare policy change.